Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) Director Bros. Advisors Lp Baker acquired 681,866 shares of Kodiak Sciences stock in a transaction that occurred on Monday, September 28th. The stock was acquired at an average cost of $88.77 per share, for a total transaction of $60,529,244.82. Following the completion of the purchase, the director […]

Inhibrx Biosciences, Inc. (NASDAQ:INBX – Get Free Report) Director Jon Kayyem bought 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 23rd. The shares were purchased at an average cost of $100.00 per share, with a total value of $500,000.00. Following the acquisition, the director directly owned 434,360 shares of […]

AFC Gamma Inc. (NASDAQ:AFCG – Get Free Report) Director Leonard Tannenbaum acquired 25,000 shares of the business’s stock in a transaction on Thursday, September 17th. The stock was acquired at an average price of $3.50 per share, with a total value of $87,500.00. Following the transaction, the director owned 6,952,446 shares in the company, valued […]

The Cooper Companies, Inc. (NASDAQ:COO – Get Free Report) Director Lawrence Kurzius purchased 10,000 shares of the stock in a transaction on Monday, September 14th. The shares were purchased at an average cost of $53.91 per share, with a total value of $539,100.00. Following the transaction, the director owned 21,099 shares of the company’s stock, […]

Dominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) CEO Anthony Hayes acquired 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 10th. The stock was bought at an average price of $2.02 per share, for a total transaction of $101,000.00. Following the completion of the transaction, the chief executive officer […]